These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6444446)

  • 1. Current status of renal transplantation.
    Rajagopalan PR; Fitts CT
    J S C Med Assoc; 1980 Jan; 76(1):21-3. PubMed ID: 6444446
    [No Abstract]   [Full Text] [Related]  

  • 2. Kidney transplantation by use of splenectomy and transfusions, cadaver haplotype matching, suppressor cell assays, and T-cell monitoring.
    Severyn W; Kyriakides G; Fuller L; Esquenazi V; Flaa C; Olson L; Goldsmith C; Miller J
    Surgery; 1981 Aug; 90(2):364-75. PubMed ID: 6454982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Masauki Hara Lecture: "The current status of renal transplantation".
    Najarian JS
    J Ark Med Soc; 1976 Sep; 73(4):170-4. PubMed ID: 134987
    [No Abstract]   [Full Text] [Related]  

  • 4. [T-suppressors in subjects treated with renal transplantation. Preliminary data].
    Renna E; Brughitta G; Cinti P; Paciucci R; Trovati A; Monari C
    Minerva Chir; 1980 May; 35(10):715-6. PubMed ID: 6450336
    [No Abstract]   [Full Text] [Related]  

  • 5. A genetic model of human histocompatibility based on the results of double cadaver renal homografts.
    Leo JR; Kilpatrick SJ; Williams GM; Hume DM; De Planque BA
    Transplant Proc; 1969 Mar; 1(1):379-81. PubMed ID: 4944243
    [No Abstract]   [Full Text] [Related]  

  • 6. Medical complications of renal transplantation.
    Orlowski T; Gradowska L
    Pol Med J; 1971; 10(2):363-70. PubMed ID: 4934230
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduction of Foxp3-expressing regulatory T cell infiltrates during the progression of renal allograft rejection in a mouse model.
    Wang S; Jiang J; Guan Q; Lan Z; Wang H; Nguan CY; Jevnikar AM; Du C
    Transpl Immunol; 2008 May; 19(2):93-102. PubMed ID: 18503884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of kidney-specific peptides and their role in renal allograft rejection.
    Poindexter NJ; Naziruddin B; Oppat W; Flye MW; Mohanakumar T
    Transplant Proc; 1995 Feb; 27(1):900-2. PubMed ID: 7879223
    [No Abstract]   [Full Text] [Related]  

  • 9. Alloantibodies and outcomes of deceased donor kidney allografts.
    Cinti P; Pretagostini R; Lai Q; Tamburro ML; Rossi M; Poli L; Berloco P
    Hum Immunol; 2009 Aug; 70(8):651-4. PubMed ID: 19527761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypically and functionally distinct CD8+ lymphocyte populations in long-term drug-free tolerance and chronic rejection in human kidney graft recipients.
    Baeten D; Louis S; Braud C; Braudeau C; Ballet C; Moizant F; Pallier A; Giral M; Brouard S; Soulillou JP
    J Am Soc Nephrol; 2006 Jan; 17(1):294-304. PubMed ID: 16338967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late acute rejection in long-term renal allograft recipients. Diagnostic and predictive value of circulating activated T cells.
    Reinke P; Fietze E; Döcke WD; Kern F; Ewert R; Volk HD
    Transplantation; 1994 Jul; 58(1):35-41. PubMed ID: 7913561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Status of kidney transplantation].
    Vahlensieck W
    Dtsch Med J; 1970 Mar; 21(6):323-30. PubMed ID: 4943291
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunology. Regulatory T cells get their chance to shine.
    Leslie M
    Science; 2011 May; 332(6033):1020-1. PubMed ID: 21617049
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-CD4 monoclonal antibody therapy of late acute rejection in renal allograft recipients--CD4+ T cells play an essential role in the rejection process.
    Reinke P; Kern F; Fietze E; Döcke WD; Ewert R; Emmrich F; Volk HD
    Transplant Proc; 1995 Feb; 27(1):859-62. PubMed ID: 7879207
    [No Abstract]   [Full Text] [Related]  

  • 16. WOFIE stimulates regulatory T cells: a 2-year follow-up of renal transplant recipients.
    Dresske B; Haendschke F; Lenz P; Ungefroren H; Jenisch S; Exner B; El Mokhtari NE; Lu T; Zavazava N; Faendrich F
    Transplantation; 2006 Jun; 81(11):1549-57. PubMed ID: 16770244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular basis of immunologic tolerance following total bowel transplantation in rats. II. Dominant role of suppressor T cells in adoptive transfer of acquired tolerance to vascularized allografts.
    Masaki Y; Oohara T; Shinomiya T; Kimura H
    Transplant Proc; 1995 Apr; 27(2):1589-92. PubMed ID: 7536972
    [No Abstract]   [Full Text] [Related]  

  • 18. Update in immunosuppression.
    Huizinga R
    Nephrol Nurs J; 2002 Jun; 29(3):261-7. PubMed ID: 12164076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intragraft mRNA cytotoxic molecule expression in renal allograft recipients.
    Carstens J; Ozbay A; Tørring C; Hansen HE
    Transpl Immunol; 2009 Mar; 20(4):212-7. PubMed ID: 19141320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.